Stay updated on Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.

Latest updates to the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision stamp updated from v3.5.3 to v3.5.4, signaling a new version of the page's documentation. The change is a minor backend update rather than a substantive alteration to study details.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe Sweden location entry in the study's locations list has been updated from Malmo to Malmö, correcting the city spelling in Skåne County. This preserves an accurate and searchable location for participants and records.SummaryDifference0.0%

- Check33 days agoChange DetectedA new related publication (on CD8+ T cells in ankylosing spondylitis) is added to the study’s publications list. The site’s displayed release/version label is updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded a new publication reference: 'Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis' (Rheumatol Ther. 2026). Updated revision to v3.5.0 (from v3.4.3).SummaryDifference0.1%

- Check83 days agoChange DetectedThe page's revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.